L

Life Science REIT PLC
LSE:LABS

Watchlist Manager
Life Science REIT PLC
LSE:LABS
Watchlist
Price: 38.8 GBX 0.52%
Market Cap: 135.8m GBX
Have any thoughts about
Life Science REIT PLC?
Write Note

Life Science REIT PLC
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Life Science REIT PLC
Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
L
Life Science REIT PLC
LSE:LABS
Cash Equivalents
£10m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Primary Health Properties PLC
LSE:PHP
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Assura PLC
LSE:AGR
Cash Equivalents
£35.4m
CAGR 3-Years
-9%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Target Healthcare REIT PLC
LSE:THRL
Cash Equivalents
£17.6m
CAGR 3-Years
-1%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Impact Healthcare REIT PLC
LSE:IHR
Cash Equivalents
£9.6m
CAGR 3-Years
-19%
CAGR 5-Years
-29%
CAGR 10-Years
N/A
No Stocks Found

Life Science REIT PLC
Glance View

Market Cap
135.8m GBX
Industry
Real Estate

Life Science Reit Plc is an investment company, which intends to carry on business as a REIT. The Company’s investment objective is to provide shareholders with a level of total return. The company will seek to achieve its investment objective by investing in a diversified portfolio of properties across the United Kingdom which are leased or intended to be leased to tenants operating in, or providing a benefit to, the life science sector. The company acquires or develops properties, such as wet and dry laboratories, offices, incubators and co-working space, manufacturing and testing facilities and data centers. The company acquires individual buildings, a group of buildings across a single science park or the entirety of a science park. This may include purchasing or developing buildings that are leased or intended to be leased to tenants providing ancillary services to employees of companies operating in, or providing a benefit to, the life science sector. The Company’s investment adviser is Ironstone Asset Management Limited.

LABS Intrinsic Value
56.87 GBX
Undervaluation 32%
Intrinsic Value
Price
L

See Also

What is Life Science REIT PLC's Cash Equivalents?
Cash Equivalents
10m GBP

Based on the financial report for Dec 31, 2023, Life Science REIT PLC's Cash Equivalents amounts to 10m GBP.

What is Life Science REIT PLC's Cash Equivalents growth rate?
Cash Equivalents CAGR 1Y
-71%

Over the last year, the Cash Equivalents growth was -71%.

Back to Top